1. Home
  2. SURG vs ITRM Comparison

SURG vs ITRM Comparison

Compare SURG & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$0.72

Market Cap

20.3M

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

SELL

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SURG
ITRM
Founded
2006
2015
Country
United States
Ireland
Employees
20
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.3M
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SURG
ITRM
Price
$0.72
$0.03
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$9.75
$9.00
AVG Volume (30 Days)
89.1K
23.7M
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.43
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.78
N/A
Revenue Next Year
$113.46
$947.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$0.03
52 Week High
$3.47
$1.42

Technical Indicators

Market Signals
Indicator
SURG
ITRM
Relative Strength Index (RSI) 34.51 26.10
Support Level N/A N/A
Resistance Level $0.95 $0.39
Average True Range (ATR) 0.07 0.02
MACD -0.00 -0.01
Stochastic Oscillator 9.69 3.34

Price Performance

Historical Comparison
SURG
ITRM

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: